111 related articles for article (PubMed ID: 8028075)
1. Functional imaging of head and neck tumors using positron emission tomography.
Zeitouni AG; Yamamoto YL; Black M; Gjedde A
J Otolaryngol; 1994 Apr; 23(2):77-80. PubMed ID: 8028075
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation.
Greven KM; Williams DW; Keyes JW; McGuirt WF; Watson NE; Randall ME; Raben M; Geisinger KR; Cappellari JO
Cancer; 1994 Aug; 74(4):1355-9. PubMed ID: 8055460
[TBL] [Abstract][Full Text] [Related]
3. The promise FDG in diagnosis and surveillance of head and neck cancer.
Mancuso AA; Drane WE; Mukherji SK
Cancer; 1994 Aug; 74(4):1193-5. PubMed ID: 8055436
[No Abstract] [Full Text] [Related]
4. Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET.
Rege SD; Chaiken L; Hoh CK; Choi Y; Lufkin R; Anzai Y; Juillard G; Maddahi J; Phelps ME; Hawkins RA
Radiology; 1993 Dec; 189(3):807-12. PubMed ID: 8234708
[TBL] [Abstract][Full Text] [Related]
5. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography.
McGuirt WF; Williams DW; Keyes JW; Greven KM; Watson NE; Geisinger KR; Cappellari JO
Laryngoscope; 1995 Apr; 105(4 Pt 1):373-5. PubMed ID: 7715380
[TBL] [Abstract][Full Text] [Related]
6. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose.
Lapela M; Grénman R; Kurki T; Joensuu H; Leskinen S; Lindholm P; Haaparanta M; Ruotsalainen U; Minn H
Radiology; 1995 Oct; 197(1):205-11. PubMed ID: 7568825
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomographic imaging of head and neck lesions.
Sakamoto H; Nakai Y; Ohashi Y; Okamura T; Ochi H
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S123-6. PubMed ID: 9065645
[TBL] [Abstract][Full Text] [Related]
8. Pet-FDG imaging in the clinical evaluation of head and neck cancer.
Wong WL; Chevretton E; McGurk M; Croft D
J R Soc Med; 1995 Aug; 88(8):469P-473P. PubMed ID: 7562832
[No Abstract] [Full Text] [Related]
9. Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry.
Haberkorn U; Strauss LG; Reisser C; Haag D; Dimitrakopoulou A; Ziegler S; Oberdorfer F; Rudat V; van Kaick G
J Nucl Med; 1991 Aug; 32(8):1548-55. PubMed ID: 1869977
[TBL] [Abstract][Full Text] [Related]
10. Recurrent rectal cancer and scar: differentiation with PET and MR imaging.
Ito K; Kato T; Tadokoro M; Ishiguchi T; Oshima M; Ishigaki T; Sakuma S
Radiology; 1992 Feb; 182(2):549-52. PubMed ID: 1732979
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted and PET/MR Imaging after Radiation Therapy for Malignant Head and Neck Tumors.
Varoquaux A; Rager O; Dulguerov P; Burkhardt K; Ailianou A; Becker M
Radiographics; 2015; 35(5):1502-27. PubMed ID: 26252192
[TBL] [Abstract][Full Text] [Related]
12. The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients.
Bailet JW; Sercarz JA; Abemayor E; Anzai Y; Lufkin RB; Hoh CK
Laryngoscope; 1995 Feb; 105(2):135-9. PubMed ID: 8544591
[TBL] [Abstract][Full Text] [Related]
13. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI.
Braams JW; Pruim J; Freling NJ; Nikkels PG; Roodenburg JL; Boering G; Vaalburg W; Vermey A
J Nucl Med; 1995 Feb; 36(2):211-6. PubMed ID: 7830116
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapeutic management of head and neck malignancies with positron emission tomography.
Reisser C; Haberkorn U; Dimitrakopoulou-Strauss A; Seifert E; Strauss LG
Arch Otolaryngol Head Neck Surg; 1995 Mar; 121(3):272-6. PubMed ID: 7873142
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography/computed tomography true fusion imaging in clinical head and neck oncology: early experience.
Yau YY; Samman N; Yeung RW
J Oral Maxillofac Surg; 2005 Apr; 63(4):479-86. PubMed ID: 15789319
[TBL] [Abstract][Full Text] [Related]
16. False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecrosis in a nasopharyngeal carcinoma patient.
Liu SH; Chang JT; Ng SH; Chan SC; Yen TC
Br J Radiol; 2004 Mar; 77(915):257-60. PubMed ID: 15020372
[TBL] [Abstract][Full Text] [Related]
17. [Evaluating the effectiveness of chemotherapy in patients with head-neck tumors using positron emission tomography (PET scan)].
Seifert E; Schadel A; Haberkorn U; Strauss LG
HNO; 1992 Mar; 40(3):90-3. PubMed ID: 1577631
[TBL] [Abstract][Full Text] [Related]
18. Head and neck cancer: detection of recurrence with three-dimensional principal components analysis at dynamic FDG PET.
Anzai Y; Minoshima S; Wolf GT; Wahl RL
Radiology; 1999 Jul; 212(1):285-90. PubMed ID: 10405755
[TBL] [Abstract][Full Text] [Related]
19. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
[TBL] [Abstract][Full Text] [Related]
20. Influence of the blood glucose concentration on FDG uptake in cancer--a PET study.
Lindholm P; Minn H; Leskinen-Kallio S; Bergman J; Ruotsalainen U; Joensuu H
J Nucl Med; 1993 Jan; 34(1):1-6. PubMed ID: 8418248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
